By Thomas Goldsmith The White House announced Monday reductions in Medicare recipients’ prescription drug costs and additional changes it said would benefit low-income people and others receiving benefits. In one change, President Donald Trump’s administration said it would reduce the maximum that people with low incomes would pay for the medicines known as biosimilars; those […]
